Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2021 Jul 23;7(4):e69-e70.
doi: 10.1093/ehjcvp/pvab008.

Omega-3 fatty acids supplementation and risk of atrial fibrillation: an updated meta-analysis of randomized controlled trials

Marco Lombardi  1 , Salvatore Carbone  2   3 , Marco Giuseppe Del Buono  1 , Juan Guido Chiabrando  4   5 , Giovanni Maria Vescovo  6 , Massimiliano Camilli  1 , Rocco Antonio Montone  1 , Rocco Vergallo  1 , Antonio Abbate  3 , Giuseppe Biondi-Zoccai  7   8 , Dave L Dixon  3   9 , Filippo Crea  1
Affiliations
Meta-Analysis

Omega-3 fatty acids supplementation and risk of atrial fibrillation: an updated meta-analysis of randomized controlled trials

Marco Lombardi et al. Eur Heart J Cardiovasc Pharmacother. .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Forest plot for atrial fibrillation events. IRR, incidence rate ratio.
See this image and copyright information in PMC

References

    1. Patel NJ, Deshmukh A, Pant S, Singh V, Patel N, Arora S, Shah N, Chothani A, Savani GT, Mehta K, Parikh V, Rathod A, Badheka AO, Lafferty J, Kowalski M, Mehta JL, Mitrani RD, Viles-Gonzalez JF, Paydak H.. Contemporary trends of hospitalization for atrial fibrillation in the United States, 2000 through 2010: implications for healthcare planning. Circulation 2014;129:2371–2379. - PubMed
    1. Lombardi M, Chiabrando JG, Vescovo GM, Bressi E, Del Buono MG, Carbone S, Koenig RA, Van Tassell BW, Abbate A, Biondi-Zoccai G, Dixon DL.. Impact of different doses of omega-3 fatty acids on cardiovascular outcomes: a pairwise and network meta-analysis. Curr Atheroscler Rep 2020;22:45. - PubMed
    1. Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, Doyle RT, Juliano RA, Jiao L, Granowitz C, Tardif J-C, Ballantyne CM; REDUCE-IT Investigators. Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia. N Engl J Med 2019;380:11–22. - PubMed
    1. Kromhout D, Giltay EJ, Geleijnse JM; For the AOTG. N-3 fatty acids and cardiovascular events after myocardial infarction. N Engl J Med 2010;363:2015–2026. - PubMed
    1. Roncaglioni MC, Tombesi M, Avanzini F, Barlera S, Caimi V, Longoni P, Marzona I, Milani V, Silletta MG, Tognoni G, Marchioli R; Risk and Prevention Study Collaborative Group. N-3 fatty acids in patients with multiple cardiovascular risk factors. N Engl J Med 2013;368:1800–1808. - PubMed

MeSH terms

Substances